First Follow-up
The patient returned for follow-up in 3 weeks.
The patient returned for follow-up in 3 weeks.
○ |
a. The patient’s experience with and ability to handle LACRISERT® (hydroxypropyl cellulose ophthalmic insert)
|
○ |
b. Changes in the patient’s vision
|
○ |
c. Tear osmolarity changes
|
○ |
d. Ocular surface evaluation
|
LACRISERT® (hydroxypropyl cellulose ophthalmic insert) is indicated in patients with moderate to severe dry eye syndromes, including keratoconjunctivitis sicca. LACRISERT is indicated especially in patients who remain symptomatic after an adequate trial of therapy with artificial tear solutions. LACRISERT is also indicated for patients with exposure keratitis, decreased corneal sensitivity, and recurrent corneal erosions.
Please see full Prescribing Information for LACRISERT® (hydroxypropyl cellulose ophthalmic insert).
The information included on this website is intended for US healthcare professionals. By agreeing, you acknowledge that you are a licensed US healthcare professional.